JAZZ FY 2011 Earnings — Jazz Pharmaceuticals plc Revenue & Financial Results | Market Cap Arena

JAZZJazz Pharmaceuticals plc

$11B

FY 2011 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$272M+56.7% YoY

Gross Profit

$258M94.9% margin

Operating Income

$128M46.9% margin

Net Income

$125M45.9% margin

EPS (Diluted)

$2.67

Cash Flow

Operating Cash Flow

$152M

Free Cash Flow

$146M

Stock-Based Comp.

$21M

Balance Sheet

Total Assets

$254M

Total Liabilities

$61M

Stockholders' Equity

$193M

Cash & Equivalents

$82M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$272M	$174M	+56.7%
Gross Profit	$258M	$160M	+61.2%
Operating Income	$128M	$58M	+121.2%
Net Income	$125M	$33M	+281.3%